Martin Jouza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Martin Jouza has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Stanikova
Department of Neonatology, University Hospital Brno, Brno, Czech Republic
1 shared publication - Julia Bohosova
Department of Biology, Faculty of Medicine, Central European Institute of Technology Masaryk University Brno Czech Republic
1 shared publication - Ondrej Slaby
Central European Institute of Technology, Masaryk University, Brno, Czech Republic
1 shared publication - Petr Jabandziev
Department of Pediatrics, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic
1 shared publication
Latest Publications
- Open Access
- 2 November 2023
- Published by BMJ in BMJ Paediatrics Open
- Vol. 7 (1) , e002172
Role of the microbiome in pathophysiology of necrotising enterocolitis in preterm neonates
Although necrotising enterocolitis (NEC) is a serious, life-threatening disease, improved neonatal care is increasing the number of survivors with NEC among extremely preterm neonates. Therapy is nevertheless mostly symptomatic and the mortality rate remains high, especially among neonates requiring surgery. Therefore, it is important to focus on preventing the disease and modifiable risk factors. NEC’s pathophysiology is multifaceted, with key factors being immaturity of the immune and barrier protective mechanisms of the premature gut and exaggerated proinflammatory reaction to insults like gut hypoxia, enteral nutrition or microbial dysbiosis. The role of the intestinal microbiome in the pathophysiology of NEC has been a subject of research for many years, but to date no specific pathogen or type of dysbiosis has been connected with NEC development. This review assesses current knowledge as to the role of the intestinal microbiota in the pathophysiology of NEC and the possibilities for positively influencing it
- 2 November 2023
- Published by BMJ in BMJ Paediatrics Open
- Vol. 7 (1) , e002172
Open AccessRole of the microbiome in pathophysiology of necrotising enterocolitis in preterm neonates
Although necrotising enterocolitis (NEC) is a serious, life-threatening disease, improved neonatal care is increasing the number of survivors with NEC among extremely preterm neonates. Therapy is nevertheless mostly symptomatic and the mortality rate remains high, especially among neonates requiring surgery. Therefore, it is important to focus on preventing the disease and modifiable risk factors. NEC’s pathophysiology is multifaceted, with key factors being immaturity of the immune and barrier protective mechanisms of the premature gut and exaggerated proinflammatory reaction to insults like gut hypoxia, enteral nutrition or microbial dysbiosis. The role of the intestinal microbiome in the pathophysiology of NEC has been a subject of research for many years, but to date no specific pathogen or type of dysbiosis has been connected with NEC development. This review assesses current knowledge as to the role of the intestinal microbiota in the pathophysiology of NEC and the possibilities for positively influencing it